主权项 |
1. A compound of Formula Iwherein:
R1 is pyrrolyl, pyrazolyl, imidazolyl, triazolyl, thiazolyl, pyridyl, pyridyl N-oxide, pyrazinyl, pyrimidinyl, pyridazyl, piperidinyl, quinazolinyl, cinnolinyl, benzothiazolyl, indazolyl, tetrahydropyranyl, tetrahydrofuranyl, furanyl, phenyl, oxazolyl, isoxazolyl, thiophenyl, benzoxazolyl, benzimidazolyl, indolyl, thiadiazolyl, oxadiazolyl or quinolinyl; wherein said pyridyl, pyridyl N-oxide, pyrazinyl, pyrimidinyl, pyridazyl, piperidinyl, quinazolinyl, cinnolinyl, benzothiazolyl, indazolyl, imidazolyl, phenyl, thiophenyl, benzoxazolyl, benzimidazolyl, indolyl, quinolinyl, and pyrazolyl are optionally substituted with C(O)C(1-4)alkyl, C(O)NH2, C(O)NHC(1-2)alkyl, C(O)N(C(1-2)alkyl)2, NHC(O)C(1-4)alkyl, NHSO2C(1-4)alkyl, C(1-4)alkyl, CF3, CH2CF3, Cl, F, —CN, OC(1-4)alkyl, N(C(1-4)alkyl)2, —(CH2)3OCH3, SC(1-4)alkyl, OH, CO2H, CO2C(1-4)alkyl, C(O)CF3, SO2CF3, OCF3, OCHF2, SO2CH3, SO2NH2, SO2NHC(1-2)alkyl, SO2N(C(1-2)alkyl)2, C(O)NHSO2CH3, or OCH2OCH3; and optionally substituted with up to two additional substituents independently selected from the group consisting of Cl, C(1-2)alkyl, SCH3, OC(1-2)alkyl, CF3, —CN, and F; and wherein said triazolyl, oxazolyl, isoxazolyl, pyrrolyl, and thiazolyl are optionally substituted with up to two substituents independently selected from the group consisting of SO2CH3, SO2NH2, C(O)NH2, —CN, OC(1-2)alkyl, (CH2)(2-3)OCH3, SCH3, CF3, F, Cl, and C(1-2)alkyl; and said thiadiazolyl and oxadiazolyl are optionally substituted with C(1-2)alkyl; and said pyridyl, pyridyl-N-oxide, pyrimidinyl, pyridazyl, and pyrazinyl are optionally substituted with up to three additional substituents independently selected from the group consisting of C(O)NHC(1-2)alkyl, C(O)N(C(1-2)alkyl)2, NHC(O)C(1-4)alkyl, NHSO2C(1-4)alkyl, C(O)CF3, SO2CF3, SO2NHC(1-2)alkyl, SO2N(C(1-2)alkyl)2, C(O)NHSO2CH3, SO2CH3, SO2NH2, C(O)NH2, —CN, OC(1-4)alkyl, (CH2)(2-3)OCH3, SC(1-4)alkyl, CF3, F, Cl, and C(1-4)alkyl; R2 is triazolyl, pyridyl, pyridyl-N-oxide, pyrazolyl, pyrimidinyl, oxazolyl, isoxazolyl, N-acetyl piperidinyl, 1-H-piperidinyl, N-Boc-piperidinyl, N-C(1-3)alkyl-piperidinyl, thiazolyl, pyridazyl, pyrazinyl, 1-(3-methoxypropyl)-imidazolyl, thiadiazolyl, oxadiazolyl, or imidazolyl; wherein said imidazolyl is optionally substituted with up to three additional substituents independently selected from the group consisting of C(1-2)alkyl, SCH3, OC(1-2)alkyl, CF3, —CN, F, and Cl; and said pyridyl, pyridyl-N-oxide, pyrimidinyl, pyridazyl, and pyrazinyl, are optionally substituted with up to three additional substituents independently selected from the group consisting of SO2CH3, SO2NH2, C(O)NH2, —CN, OC(1-2)alkyl, (CH2)(2-3)OCH3, SCH3, CF3, F, Cl, or C(1-2)alkyl; and said triazolyl, thiazolyl, oxazolyl and isoxazolyl are optionally substituted with up to two substituents independently selected from the group consisting of SO2CH3, SO2NH2, C(O)NH2, —CN, OC(1-2)alkyl, (CH2)(2-3)OCH3, SCH3, CF3, F, Cl, and C(1-2)alkyl; and said thiadiazolyl and oxadiazolyl are optionally substituted with C(1-2)alkyl; and said pyrazolyl is optionally substituted with up to three CH3 groups; R3 is H, OH, OCH3, or NH2; R4 is H, or F; R5 is H, Cl, —CN, CF3, SC(1-4)alkyl, OC(1-4)alkyl, OH, C(1-4)alkyl, N(CH3)OCH3, NH(C(1-4)alkyl), N(C(1-4)alkyl)2, or 4-hydroxy-piperidinyl; R6 is —O-phenyl, —NHphenyl, —N(C(1-3)alkyl)phenyl, —N(CO2C(CH3)3)phenyl, N(COCH3)phenyl, —O-pyridyl, —NHpyridyl, —N(C(1-3)alkyl)pyridyl, N(CO2C(CH3)3)pyridyl, N(COCH3)pyridyl, —O-pyrimidinyl, —NHpyrimidinyl, —N(C(1-3)alkyl)pyrimidinyl, N(CO2C(CH3)3)pyrimidinyl, N(COCH3)pyrimidinyl, —O-pyridazyl, —NHpyridazyl, —N(C(1-3)alkyl)pyridazyl, N(CO2C(CH3)3)pyridazyl, N(COCH3)pyridazyl, —O-pyrazinyl, —NHpyrazinyl, —N(C(1-3)alkyl)pyrazinyl, N(CO2C(CH3)3)pyrazinyl, or N(COCH3)pyrazinyl; wherein said pyrimidinyl, pyridazyl, or pyrazinyl are optionally substituted with Cl, F, CH3, SCH3, OC(1-4)alkyl, —CN, CONH2, SO2NH2, or SO2CH3; and wherein said phenyl or said pyridyl is optionally substituted up to two times with OCF3, SO2C(1-4)alkyl, CF3, CHF2, pyrazolyl, triazolyl, imidazolyl, tetrazolyl, oxazolyl, thiazolyl, C(1-4)alkyl, C(3-4)cycloalkyl, OC(1-4)alkyl, N(CH3)2, SO2NH2, SO2NHCH3, SO2N (CH3)2, CONH2, CONHCH3, CON(CH3)2, Cl, F, —CN, CO2H, OH, CH2OH, NHCOC(1-2)alkyl, COC(1-2)alkyl, SCH3, CO2C(1-4)alkyl, NH2, NHC(1-2)alkyl, or OCH2CF3; wherein the selction of each optional substituent is independent; and wherein said pyrazolyl, triazolyl, imidazolyl, tetrazolyl, oxazolyl, and thiazolyl are optionally substituted with CH3; R7 is H, Cl, —CN, C(1-4)alkyl, OC(1-4)alkylCF3, OCF3, OCHF2, OCH2CH2OC(1-4)alkyl, CF3, SCH3, C(1-4)alkylNA1A2, CH2OC(2-3)alkylNA1A2, NA1A2, C(O)NA1A2, CH2NHC(2-3)alkylNA1A2, CH2N(CH3)C(2-3)alkylNA1A2,NHC(2-3)alkylNA1A2, N(CH3)C(2-4)alkylNA1A2, OC(2-4)alkylNA1A2, OC(1-4)alkyl, OCH2-(1-methyl)-imidazol-2-yl, phenyl, thiophenyl, furyl, pyrazolyl, imidazolyl, pyridyl, pyridazyl, pyrazinyl, or pyrimidinyl; wherein said phenyl, thiophenyl, furyl, pyrazolyl, imidazolyl, pyridyl, pyridazyl, pyrazinyl, and pyrimidinyl are optionally substituted with up to three substituents independently selected from the group consisting of F, Cl, CH3, CF3, and OCH3; A1 is H, or C(1-4)alkyl; A2 is H, C(1-4)alkyl, C(1-4)alkylOC(1-4)alkyl, C(1-4)alkylOH, C(O)C(1-4)alkyl, or OC(1-4)alkyl; or A1 and A2 may be taken together with their attached nitrogen to form a ring selected from the group consisting of: Ra is H, OC(1-4)alkyl, CH2OH, NH(CH3), N(CH3)2, NH2, CH3, F, CF3, SO2CH3, or OH; Rb is H, CO2C(CH3)3, C(1-4)alkyl, C(O)C(1-4)alkyl, SO2C(1-4)alkyl, CH2CH2CF3, CH2CF3, CH2-cyclopropyl, phenyl, CH2-phenyl, or C(3-6)cycloalkyl; R8 is H, C(1-3)alkyl, OC(1-3)alkyl, CF3, NH2, NHCH3, —CN, or F; R9 is H, or F;and pharmaceutically acceptable salts thereof. |